Consumption of sweetened, dried cranberries may reduce urinary tract infection incidence in susceptible women - A modified observational study

Nutrition Journal

Volumn 12, Issue 1, 2013, Pages

  Burleigh, Alexandra E ^a   Benck, Susan M ^b   McAchran, Sarah E ^a   Reed, Jess D ^c   Krueger, Christian G ^c   Hopkins, Walter J ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b University of Wisconsin Health   (United States)

^c UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Cranberry; E. coli; Prevention; Recurrent; Urinary tract infection

Indexed keywords

DNA; VIRULENCE FACTOR;

ADULT; ARTICLE; BACTERIUM ISOLATION; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; CRANBERRY; DIET THERAPY; DISEASE PREDISPOSITION; DNA FINGERPRINTING; ESCHERICHIA COLI; FEMALE; FOOD INTAKE; HUMAN; KAPLAN MEIER METHOD; MORBIDITY; OBSERVATIONAL STUDY; POLYMERASE CHAIN REACTION; URINARY TRACT INFECTION;

BACTERIA (MICROORGANISMS); VACCINIUM MACROCARPON;

ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; FEMALE; FRUIT; HUMANS; INCIDENCE; KAPLAN-MEIER ESTIMATE; MIDDLE AGED; RECURRENCE; URINARY TRACT INFECTIONS; VACCINIUM MACROCARPON; VIRULENCE FACTORS; YOUNG ADULT;

EID: 84885526237     PISSN: None     EISSN: 14752891     Source Type: Journal    
DOI: 10.1186/1475-2891-12-139     Document Type: Article

References (30)

1. Acute uncomplicated urinary tract infection in women. Fihn SD, N Engl J Med 2003 349 259 266 10.1056/NEJMcp030027 12867610
2. Urologic diseases in America project: trends in resource use for urinary tract infections in women. Griebling TL, J Urol 2005 173 1281 1287 10.1097/01.ju.0000155596.98780.82 15758783
3. Recurrent urinary tract infections: incidence and risk factors. Foxman B, Am J Public Health 1990 80 331 333 10.2105/AJPH.80.3.331 2305919
4. Antibiotics for preventing recurrent urinary tract infection in non-pregnant women. Albert X, Huertas I, Pereiro II, et al. Cochrane Database Syst Rev 2004 3 CD001209
5. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: 2010 update by the infectious diseases society of America and the European society for microbiology and infectious diseases. Gupta K, Hooton TM, Naber KG, et al. Clin Infect Dis 2011 52 5 103 e120 10.1093/cid/ciq257 21292654
6. Post-intercourse versus daily ciprofloxacin prophylaxis for recurrent urinary tract infections in premenopausal women. Melekos MD, Asbach HW, Gerharz E, et al. J Urol 1997 157 935 939 10.1016/S0022-5347(01)65087-0 9072603
7. Nitrofurantoin induced pulmonary fibrosis: a case report. Goemaere N, Grijm K, van Hal P, et al. J Med Case Reports 2008 2 169 173 10.1186/1752-1947-2-169
8. Recurrent uncomplicated urinary tract infections in women: a review. Nosseir SB, Lind LR, Winkler HA, J Womens Health 2012 21 347 354 10.1089/jwh.2011.3056
9. Randomised trial of cranberry-lingonberry juice and Lactobacillus GG drink for the prevention of urinary tract infections in women. Kontiokari T, Sundqvist K, Nuutinen M, et al. BMJ 2001 322 1571 10.1136/bmj.322.7302.1571 11431298
10. Cranberries for preventing urinary tract infections. Jepson JP, Craig JC, Cochrane Database Syst Rev 2008 1 CD001321
11. Cranberry juice fails to prevent recurrent urinary tract infection: results from a randomized placebo controlled trial. Barbosa-Cesnik C, Brown MB, Buxton M, et al. Clin Infect Dis 2011 52 23 30 10.1093/cid/ciq073 21148516
12. Dosage effect on uropathogenic Escherichia coli anti-adhesion activity in urine following consumption of cranberry powder standardized for proanthocyanidin content: a multicentric randomized double blind study. Howell AB, Botto H, Combescure C, et al. BMC Infect Dis 2010 10 94 10.1186/1471-2334- 10-94 20398248
13. PapG alleles of Escherichia coli strains causing first-episode or recurrent acute cystitis in adult women. Johnson JR, Russo TA, Brown JJ, et al. J Infect Dis 1998 177 97 101 10.1086/513824 9419175
14. Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Foxman B, Am J Med 2002 113 5 13
15. Pathogenic Escherichia coli. Kaper JB, Nataro JP, Mobley HL, Nat Rev Microbiol 2004 2 123 140 10.1038/nrmicro818 15040260
16. On information and sufficiency. Kullback S, Leibler RA, Ann Math Stat 1951 22 79 86 10.1214/aoms/1177729694
17. The homogeneity of the faecal coliform flora of normal school-girls, characterized by serological and biochemical properties. Lidin-Janson G, Kaijser B, Lincoln K, et al. Med Microbiol Immunol 1978 164 247 253 10.1007/BF02125493 45599
18. Genomic fingerprinting of bacteria using repetitive sequence-based polymerase chain reactions. Versalovic J, Schneider M, DeBrujin FJ, et al. Methods Mol Cel Biol 1994 5 25 40
19. Confirmation Identification of Escherichia coli, a comparison of genotypic and phenotypic assays for glutamate decarboxylase and beta-D-glucuronidase. McDaniels AE, Rice EW, Reyes AL, et al. Appl Environ Microbiol 1996 62 3350 3354 8795225
20. Extended virulence genotypes of Escherichia coli strains from patients with urosepsis in relation to phylogeny and host compromise. Johnson JR, Stell AL, J Infect Dis 2000 181 261 272 10.1086/315217 10608775
21. Presence of putative repeat-in-toxin gene tosA in Escherichia coli predicts successful colonization of the urinary tract. Vigil PD, Stapleton AE, Johnson JR, et al. mBio 2011 2 3 00066 11 21540363
22. Rapid and simple determination of the Escherichia coli phylogenetic group. Clermont O, Bonacorsi S, Bingen E, Appl Environ Mircrobiol 2000 66 4555 4558 10.1128/AEM.66.10.4555-4558.2000
23. Pathogenicity island markers in commensal and uropathogenic Escherichia coli isolates. Sabaté M, Moreno E, Pérez E, et al. Clin Microbiol Infect 2006 12 880 886 10.1111/j.1469-0691.2006.01461.x 16882293
24. Vaginal mucosal vaccine for recurrent urinary tract infections in women: results of a phase 2 clinical trial. Hopkins WJ, Elkahwaji JE, Beierle LM, et al. J Urol 2007 177 1349 1353 10.1016/j.juro.2006.11.093 17382730
25. Trans-cinnamaldehyde decreases attachment and invasion of uropathogenic Escherichia coli in urinary tract epithelial cells by modulating virulence gene expression. Amalaradjou MAR, Narayanan A, Venkitanarayanan K, J Urol 2011 185 1526 1531 10.1016/j.juro.2010.11.078 21334666
26. Cinnamaldehyde and cinnamaldehyde derivatives reduce virulence in vibrio spp. By decreasing the DNA-binding activity of the quorum sensing response regulator LuxR. Brackman G, Defoirdt T, Miyamoto C, et al. BMC Microbiol 2008 8 149 10.1186/1471-2180-8-149 18793453
27. Inhibition of Escherichia coli CFT073 fliC expression and motility by cranberry materials. Hidalgo G, Chan M, Tufenkji N, App Environ Microbiol 2011 77 6852 6857 10.1128/AEM.05561-11
28. Inhibition of swarming and virulence factor expression in Proteus mirabilis by resveratrol. Wang W-B, Lai H-C, Hsueh P-R, et al. J Med Microbiol 2006 55 1313 1321 10.1099/jmm.0.46661-0 17005777
29. Cranberry proanthocyanidins improve intestinal sIgA during elemental enteral nutrition. Pierre JF, Heneghan AF, Feliciano RP, et al. JPEN J Parenter Enteral Nutr 2013 Epub ahead of print
30. Cranberry phytochemicals modify human immune function and appear to reduce the severity of cold and flu symptoms. Nantz MP, Rowe CA, Muller CE, et al. FASEB J 2010 24 326.6